Search trials



Primary RegistryProtocol numberPublic titleScientific titleType of studyRecruitment statusLast updated
LBCTR2023065390FM446Effects of a mindfulness program on the welfare of university studentsThe effects of a mindfulness program on the reduction of symptoms of anxiety and depression and on the perception of pain and stress in university studentsInterventionalRecruiting21/06/2023
LBCTR2023065392 CEHDF2110Comparison of the impact of two NEurofeedback EEG protocols on the perception and threshold of experimental pain in healthy subjectsPhysiological and validation study in healthy subjects of the effect of two Neurofeedback protocols on acute pain - clinical trial.InterventionalRecruiting29/06/2023
LBCTR2022054889CBYL719G12301Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA MutationEPIK-B2: A Two Part, Phase III, Multicenter, Randomized (1:1), Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA MutationInterventionalSuspended04/11/2021
LBCTR2023015151CLOU064C12301Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple SclerosisA Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label RemibrutinibInterventionalPending14/10/2022
LBCTR2023075403MK7-003ViKEMVitamin K2 Supplementation in Adult Episodic MigraineInterventionalPending24/07/2023
LBCTR2019010184CLEE011A2404COMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced DiseaseCOMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced DiseaseInterventionalComplete11/01/2019
LBCTR2019080232CLEE011F2301Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer ( MONALEESA 3)A Randomized Double-blind, Placebo-controlled Study of Ribociclib in Combination With Fulvestrant for the Treatment of Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer Who Have Received no or Only One Line of Prior Endocrine Treatment InterventionalComplete06/05/2019
LBCTR2024015424CHS1221A Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Safety and Efficacy of Once-Daily and Twice-Daily Dosing of a Novel Hydrocortisone Acetate 90 mg Suppository Formulation Administered with the Sephure® Suppository Applicator in Subjects with Ulcerative Colitis of the RectumA Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Safety and Efficacy of Once-Daily and Twice-Daily Dosing of a Novel Hydrocortisone Acetate 90 mg Suppository Formulation Administered with the Sephure® Suppository Applicator in Subjects with Ulcerative Colitis of the RectumInterventionalRecruiting04/09/2023
LBCTR2023095432PIDMR3Evaluation of Pharmacist-Initiated Discharge Medication Reconciliation and Patient Counseling Procedures in the Emergency DepartmentEvaluation of Pharmacist-Initiated Discharge Medication Reconciliation and Patient Counseling Procedures in the Emergency DepartmentInterventionalComplete08/11/2023
LBCTR2023065377N/AImpact of Health Literacy on Multiple Patient Variables: A Single-Center Observational Study in LebanonImpact of Health Literacy on Multiple Patient Variables: A Single-Center Observational Study in LebanonObservationalComplete14/06/2023
items per page111 - 120 of 174 items